Retos de hoy en Medicina Intensiva: diversidad, equidad e inclusión. Posicionamiento de género de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) / Challenges in intensive medicine: Diversity, equity and inclusion. Gender statement of the Spanish Society of Intensive and Critical Medicine and Coronary Units (SEMICYUC)

El género es un determinante social que impacta en el ámbito de la salud y genera desigualdades a todos los niveles; repercute en los pacientes y en la patología crítica, en los profesionales y en el desarrollo de la carrera profesional y las sociedades científicas, desde una perspectiva de justicia social. Todas las sociedades científicas internacionales de medicina intensiva comprometidas en aportar una perspectiva de género coinciden en la necesidad de un compromiso formal por parte de las instituciones. La Sociedad de Medicina Intensiva y Unidades Coronarias (SEMICYUC) se compromete a velar por la equidad, la inclusión y la representatividad de sus profesionales y combatir la brecha de género en el ámbito de la medicina intensiva (AU)

Gender is a social determinant that impacts on health and generates inequities at all levels; it has an impact on patients and critical pathology, professionals and professional career development, and scientific societies, from a social justice perspective. All the international scientific societies of Intensive Care Medicine committed to contributing a gender perspective agree on the need for a formal positioning by the institutions. The Society of Intensive Medicine and Coronary Units (SEMICYUC) is committed to ensuring the equity, inclusion and representativeness of its professionals and combating the gender gap in the field of Intensive Medicine (AU)

[Updates on severe traumatic brain injury management]. / Actualizaciones en el manejo del traumatismo craneoencefálico grave.

Traumatic brain injury (TBI) is an important reason of morbidity-mortality all over the world, affecting young males more and generating Public Health problem. Unfortunately, the advances in the pathophysiology knowledge have not followed a similar development in therapeutic options, there currently not being any contrasted neuroprotectants. In this article, we have reviewed the epidemiology, pathophysiology and therapeutic measures used in the management of patient with severe TBI. The general measures as well as those aimed at controlling intracranial hypertension, the role of the surgery and some more innovative therapeutic options currently under evaluation in these patients are analyzed.